Dzvanya apa kana iri pepanhau rako!

Losartan High Blood Pressure Mushonga Zvino Wayeuka

rakanyorwa mupepeti

Mint Pharmaceuticals Inc. iri kurangarira ese akawanda emapiritsi ayo ekurapa losartan, mune 50 mg uye 100 mg masimba, mushure mekuedzwa kwakawanikwa kusvibiswa kweazido (5-(4′-((5-(azidomethyl)-2-butyl-4-chloro) -1H imidazol-1-yl) methyl) - [1,1′-biphenyl]-2-yl) -1H tetrazole) pamusoro pemuganhu unogamuchirwa. Kuratidzwa kwenguva refu nekusachena pamatanho ari pamusoro pezvinonzi zvakachengeteka zvinogona kuwedzera njodzi yegomarara.

Print Friendly, PDF & Email

Ndokumbira utarise iyo yakazara kuraira kuti uwane rumwe ruzivo, kusanganisira izvo vanhu vekuCanada vanofanira kuita uye Health Canada basa rekugadzirisa nyaya yekusachena kweazido inowanikwa mune mamwe mishonga.

chigadzirwakambaniDINRotiKupera
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896572005006959April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896572005006960April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896572005006961April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896572005006962April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896572005006963April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896572005011154June 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896572005011156June 2023
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896652005006807April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896652005006808April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896652005006809April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896652005006810April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS Nhoroondo ye Mint Pharmaceuticals Inc.023896652105002149December 2022
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896731805012687October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896731805012688October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896731805012689October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896731805012792October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896731905001010December 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS Nhoroondo ye Mint Pharmaceuticals Inc.023896731905001011December 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896732005006947April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896732005006949April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896732005006950April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896732005006951April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS Nhoroondo ye Mint Pharmaceuticals Inc.023896732005007297April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896732005007298April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896732005013776August 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSNhoroondo ye Mint Pharmaceuticals Inc.023896732105002150December 2023
Print Friendly, PDF & Email

Nezvomunyori

mupepeti

Mupepeti mukuru ndiLinda Hohnholz.

Leave a Comment